Galderma Investigational Site 8726

Wilmington, North Carolina 28405-3176

0 studies enrolling now · 1 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling